Fibrobiologics Says On Sept 19, Entered Into A Master Services Agreement With Charles River Laboratories; Agreement Term Expires On Sept 19, 2029, Unless Earlier Terminated By Either Party In Accordance With Agreement
Portfolio Pulse from Benzinga Newsdesk
Fibrobiologics has entered into a Master Services Agreement with Charles River Laboratories, effective from September 19, 2023, to September 19, 2029, unless terminated earlier by either party.
September 24, 2024 | 8:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Charles River Laboratories has entered into a long-term Master Services Agreement with Fibrobiologics, potentially enhancing its service offerings and client base.
The agreement with Fibrobiologics could expand Charles River Laboratories' service offerings and client base, positively impacting its business operations and revenue potential.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Fibrobiologics has secured a Master Services Agreement with Charles River Laboratories, which could enhance its research and development capabilities.
The partnership with Charles River Laboratories could provide Fibrobiologics with enhanced research and development capabilities, potentially leading to advancements in its biotech projects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80